Examination of Fiscal Management and the Allocation of Care Act Resources US Department of Health and Human Services: Health REsources and Services Administration
INTRODUCTION
HIV/HCV Coinfection
HCV Treatment
Expanding Access to Treatment
Barriers and Key Issues
HCV Treatment: Estimating the Cost
Working With Patients Who Have Multiple Needs
Concerns About Relapse to Active Drug Use and Reinfection
Depression and HCV Treatment
Treatment Eligibility and Uptake
Treating Anemia and Neutropenia With Growth Factors
Access to HCV Treatment and ADAPs
Conclusion
Resources
References

Depression and HCV Treatment

Depression is a common comorbidity of HIV and HCV, and it is common among drug users.152-157 Treating depression among PLWHA has improved adherence to antiretroviral therapy158 and is a key management strategy for interferon-induced depression.

Schaefer and colleagues reported that patients with a psychiatric history were successfully treated for HCV when a pretreatment psychiatric evaluation and ongoing multidisciplinary care were offered with HCV treatment.110 Some clinicians and patients prefer to start antidepressants prior to HCV treatment, whereas others favor antidepressant use only if it becomes necessary. Because treatment discontinuations often occur due to psychiatric adverse events, it is sensible to avert such events when possible by incorporating mental health care into HCV treatment planning.

 

 

 
 
<< Concerns About Relapse to Active Drug Use and Reinfection • Treatment Eligibility and Uptake >>